Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Hou

Bushinksy

Wish

Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243–8.

Thomsen

. Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine? Eur Radiol 2001;11:2351–3.

McCullough

Wolyn

Rocher

Levin

O'Neil

. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368–67.

Levy

Viscoli

Horwitz

. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996;275:1489–94.

Morcos

Thomsen

Webb

JAW

Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999;9:1602–13.

Murphy

Barrett

Parfrey

. Contrast nephropathy. J Am Soc Nephrol 2000;11:177–82.

Sandler

. Contrast-agent-induced acute renal dysfunction — is iodixanol the answer? N Engl J Med 2003;348:551–3.

Barrett

Carlisle

. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171–8.

Rudnick

Berns

Cohen

Contrast-media associated nephrotoxicity. Semin Nephrol 1997;17:15–26.

10.

Rich

Crecelius

. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. Arch Intern Med 1995;150:1237–42.

11.

Tepel

Zidek

. Acetylcysteine for radiocontrast nephropathy. Curr Opin Crit Care 2001;7:390–2.

12.

Brophy

. Role of n-acetylcysteine in the prevention of radiocontrast-induced nephropathy. Ann Pharmacother 2002;36:1466–70.

13.

Efrati

Dishy

Averbukh

The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 2003;64(6):2182–7.

14.

Tepel

Van der Giet

Schwarzfeld

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180–4.

15.

Diaz-Sandoval

Kosowsky

Losordo

. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002;89:356–8.

16.

Briguori

Manganelli

Scarpato

Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:298–303.

17.

Shyu

Cheng

Kuan

. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002;40:1383–8.

18.

Kay

Chow

Chan

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. JAMA 2003;289:553–8.

19.

Durham

Caputo

Dokko

A randomized controlled trial of n-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002;62:2202–7.

20.

Allaqaband

Tumuluri

Malik

Prospective randomized study of n-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Intervent 2002;57:279–83.

21.

Boccalandro

Amhad

Smalling

Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Cathet Cardiovasc Intervent 2003;58:336–41.

22.

Tadros

Mouhayar

Akinwande

Prevention of radiocontrast-induced nephropathy with n-acetylcysteine in patients undergoing coronary angiography. J Invas Cardiol 2003;15:311–4.

23.

Oldemeyer

Biddle

Wurdeman

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am Heart J 2003;146:E23.

24.

Birck

Krzossok

Markowetz

Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362:598–603.

25.

Isenbarger

Kent

O'Malley

. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003;92:1454–8.

26.

Kellum

. A drug to prevent renal failure? [Editorial]. Lancet 2003;362:589–90.

27.

Bagshaw

Culleton

. Acetylcysteine and renal function following coronary angiographic procedures (letter). JAMA 2003;289:2795.

28.

Lepor

. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and n-acetylcysteine. Rev Cardiovasc Med 2003;4 Suppl 1:S15–20.

29.

Shen

. Acetylcysteine and renal function following coronary angiographic procedures (letter). JAMA 2003;289:2794–5.

30.

Briguori

Tavano

Colombo

. Contrast agent-associated nephrotoxicity. Prog Cardio Dis 2003;45:493–503.

31.

Briguori

Colombo

Violante

Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004;25:188–9.

32.

Mueller

Buerkle

Buettner

Prevention of contrast media-associated nephropathy. Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:32936.

33.

Taylor

Hotchkiss

Morse

PREPARED: Preparation for angiography in renal dysfunction. A randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998;114:1570–4.

34.

Waybill

. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3–9.

35.

Mucomyst product monograph. In: Repchinsky

, editor. Compendium of pharmaceuticals and specialties. Ottawa: Canadian Pharmacists Association; 2003.

Oral N-Acetylcysteine (NAC) to Prevent Contrast-Induced Nephrotoxicity: Is NAC the Answer?

Abstract

Get full access to this article

References